Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2020-07-30 8:02 pm Sale | 2020-07-28 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | ARMISTICE CAPITAL LLC | 0 0.000% | -1,460,019 (Position Closed) | Filing History |
| 2020-07-29 5:18 pm Purchase | 2020-07-28 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 7,263,236 100.000% | 6,178,236 (+569.42%) | Filing History |
| 2020-06-30 5:37 pm Unchanged | 2020-06-29 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 0 (Unchanged) | Filing History |
| 2020-06-30 4:37 pm Unchanged | 2020-06-24 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | ARMISTICE CAPITAL LLC | 1,460,019 19.990% | 0 (Unchanged) | Filing History |
| 2020-06-25 9:58 pm Unchanged | 2020-06-24 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 0 (Unchanged) | Filing History |
| 2020-06-22 5:17 pm Purchase | 2020-06-15 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | LA JOLLA PHARMACEUTICAL CO LJPC | 1,085,000 14.900% | 1,085,000 (New Position) | Filing History |
| 2020-06-11 4:38 pm Purchase | 2020-06-04 | 13D | TETRAPHASE PHARMACEUTICALS INC TTPH | ARMISTICE CAPITAL LLC | 1,460,019 19.990% | 40,512 (+2.85%) | Filing History |